WISDOMONT BIOTECH FUND LLC
Raised
$960K
Investors
12
Min Invest
None stated
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
AltStreet Analysis
·Generated from EDGAR primary sources
Wisdomont Biotech Fund LLC is a Delaware-organized pooled investment fund that filed an original Form D on 2021-07-09, reporting $960K raised from 12 investors under the 506(b) exemption combined with the 3(c)(1) exclusion. The filing lists Wisdomont Asset Management and Kai Chen as executive officers/related persons; minimum investment and first sale date are not disclosed on the filing, and no related platform or sibling entities were identified.
This filing follows a common structure for small private pooled investment vehicles: a 506(b) exemption paired with the 3(c)(1) exclusion, which is typical for funds limiting investors to under 100 to avoid Investment Company Act registration. At $960K across 12 investors (an average check of roughly $80K), this is a small-scale raise relative to typical institutional alternative investment offerings, and the minimum investment amount is not disclosed, which is routine for this filing type.
Data Flags
Critical Disclosures
What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.
Reporting lapsed · Form D · last filing July 9, 2021
Offering declared to continue beyond a year; annual amendment 13+ months overdue An issuer that stops filing is the case the going-concern flag cannot catch: the report that would have carried it was never filed.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
dark
Investor
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
N/A WISDOMONT ASSET MANAGEMENT
Executive Officer · REDWOOD CITY, CA
KAI CHEN
Executive Officer · REDWOOD CITY, CA
Questions About WISDOMONT BIOTECH FUND LLC
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is WISDOMONT BIOTECH FUND LLC?
WISDOMONT BIOTECH FUND LLC is a Delaware limited liability company that filed a Form D with the SEC on July 9, 2021 as a venture capital fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1) for an offering of pooled investment fund interests.
Is WISDOMONT BIOTECH FUND LLC legit?
AltStreet does not rate legitimacy; it reports the public record. WISDOMONT BIOTECH FUND LLC filed a Form D with the SEC on July 9, 2021 claiming Rule 506(b), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $960,000 sold to 12 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is WISDOMONT BIOTECH FUND LLC registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that WISDOMONT BIOTECH FUND LLC claimed Rule 506(b), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has WISDOMONT BIOTECH FUND LLC raised?
WISDOMONT BIOTECH FUND LLC reported $960,000 sold from 12 investors in an offering of indefinite size as of the Form D filed July 9, 2021.
Who can invest in WISDOMONT BIOTECH FUND LLC?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.
What is the minimum investment in WISDOMONT BIOTECH FUND LLC?
The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.
Who is selling WISDOMONT BIOTECH FUND LLC and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.
Who is behind WISDOMONT BIOTECH FUND LLC?
The Form D lists 2 related persons: WISDOMONT ASSET MANAGEMENT, executive officer; KAI CHEN, executive officer. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is WISDOMONT BIOTECH FUND LLC located?
The issuer's address on its SEC filings is 275 Shoreline Drive, Suite 120, Redwood City, CA 94065. Its phone number of record is 4154327580. It is organized under the laws of Delaware.
How long is the WISDOMONT BIOTECH FUND LLC offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.
How large is WISDOMONT BIOTECH FUND LLC?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.